SCHEMBL8203094

SCHEMBL8203094

COc1ccc2c(O[C@H]3CN[C@H](C(N)=O)C3)cc(-c3ccccc3)nc2c1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
ALDH1A1 P00352 3/20 0.55
TACR3 P29371 8/20 0.47
PLA2G2A P14555 1/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
MAPT P10636 4/20 0.43
HPGD P15428 3/20 0.43
LMNA P02545 2/20 0.43
HTT P42858 2/20 0.43
ACACA Q13085 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
CTSB P07858 1/20 0.42
NPC1 O15118 1/20 0.41
MITF O75030 1/20 0.41
RAB9A P51151 1/20 0.41
PAX8 Q06710 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3052280 0.93 KDM4E (0.57) KDM4ESMN1; SMN2ALDH1A1TACR3PLA2G2A
SCHEMBL4981224 0.93 KDM4E (0.57) KDM4ESMN1; SMN2ALDH1A1TACR3PLA2G2A
SCHEMBL5692604 0.93 KDM4E (0.57) KDM4ESMN1; SMN2ALDH1A1TACR3PLA2G2A
SCHEMBL8354904 0.91 KDM4E (0.55) KDM4ESMN1; SMN2ALDH1A1TACR3PLA2G2A
SCHEMBL4617427 0.91 KDM4E (0.55) KDM4ESMN1; SMN2ALDH1A1TACR3PLA2G2A
SCHEMBL7095755 0.89 KDM4E (0.51) KDM4ESMN1; SMN2ALDH1A1TACR3PLA2G2A
SCHEMBL13451464 0.85 KDM4E (0.48) KDM4ESMN1; SMN2ALDH1A1TACR3PLA2G2A
SCHEMBL13176984 0.84 KDM4E (0.62) KDM4ESMN1; SMN2ALDH1A1TACR3PLA2G2A
SCHEMBL13282799 0.83 KDM4E (0.57) KDM4ESMN1; SMN2ALDH1A1TACR3PLA2G2A
Hydrochloric Acid SCHEMBL2709962 0.83 DPP4 (0.47) KDM4ESMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9694086-B2 HCV protease inhibitors and uses thereof CELGENE CAR LLC (BM) 2017-07-04 US disclosed
WO-2008033389-A2 MACROCYCLIC HCV INHIBITORS AND THEIR USES NOVARTIS AG (CH) 2008-03-20 WO disclosed